𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination cyclophosphamide, adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer

✍ Scribed by Ronald B. Natale; Brenda Shank; Basil S. Hilaris; Robert E. Wittes

Book ID
115680555
Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
750 KB
Volume
79
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of small cell lung cancer with
Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy
✍ H. CortΓ©s Funes; P. Dominguez; A. Perez Torrubia; E. Lanzos; M. Mendez; C. Mendi πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 505 KB

Fifty five patients with small cell lung cancer with treated with VP16-213 combination chemotherapy regimen in two consecutive series. The first series included 24 patients; 10 with limited and 14 with extensive disease were treated with VP16-213, 120 mg/m2 p.o. daily for 5 consecutive days, Cycloph

Chemotherapy combination with cyclophosp
Chemotherapy combination with cyclophosphamide (CTX) adriamycin (ADM), vincristine (VCR), and VP16-213 in small cell carcinoma of the lung (SCCL)
✍ J. M. Gracia; A. Jimenez πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 178 KB

Twenty-four evaluable patients with small cell carcinoma of the lung were treated with an escalating chemotherapy regimen including Cyclophosphamide, Adriamycin, Vincristine and VP16-213. The initial doses were CTX 800 mg/m2 i.v. day 1; ADR 50 mg/m2 i.v. day 1; VCR 1.4 mg/m2 day 1 weekly; and VP16-2